カテゴリ： 世界, 医療/バイオ, Market Monitor Global

微生物抗菌薬のグローバル市場展望 2023年-2029年：経口剤、腸溶性カプセル

■ 英語タイトル：Microbial Antibacterial Drugs Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14425）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14425
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：138
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[微生物抗菌薬のグローバル市場展望 2023年-2029年：経口剤、腸溶性カプセル]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の微生物抗菌薬市場規模と予測を収録しています。・世界の微生物抗菌薬市場：売上、2018年-2023年、2024年-2029年
・世界の微生物抗菌薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の微生物抗菌薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経口剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

微生物抗菌薬のグローバル主要企業は、Seres Therapeutics、 Assembly Biosciences、 Synthetic Biologics、 Interxon、 PureTech、 Synlogic、 Enterome BioScience、 4D Pharma、 Second Genome、 AOBiome、 Rebiotix、 Metabiomics、 Ritter Pharmaceuticals、 Symberix、 OpenBiome、 Azitra、 Oselなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、微生物抗菌薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の微生物抗菌薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の微生物抗菌薬市場：タイプ別市場シェア、2022年
・経口剤、腸溶性カプセル

世界の微生物抗菌薬市場：用途別、2018年-2023年、2024年-2029年
世界の微生物抗菌薬市場：用途別市場シェア、2022年
・消化器疾患、自己免疫疾患、糖尿病、癌、その他

世界の微生物抗菌薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の微生物抗菌薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における微生物抗菌薬のグローバル売上、2018年-2023年
・主要企業における微生物抗菌薬のグローバル売上シェア、2022年
・主要企業における微生物抗菌薬のグローバル販売量、2018年-2023年
・主要企業における微生物抗菌薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Seres Therapeutics、 Assembly Biosciences、 Synthetic Biologics、 Interxon、 PureTech、 Synlogic、 Enterome BioScience、 4D Pharma、 Second Genome、 AOBiome、 Rebiotix、 Metabiomics、 Ritter Pharmaceuticals、 Symberix、 OpenBiome、 Azitra、 Osel

*************************************************************

・調査・分析レポートの概要
微生物抗菌薬市場の定義
市場セグメント
世界の微生物抗菌薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の微生物抗菌薬市場規模
世界の微生物抗菌薬市場規模：2022年 VS 2029年
世界の微生物抗菌薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの微生物抗菌薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の微生物抗菌薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：経口剤、腸溶性カプセル
微生物抗菌薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：消化器疾患、自己免疫疾患、糖尿病、癌、その他
微生物抗菌薬の用途別グローバル売上・予測

・地域別市場分析
地域別微生物抗菌薬市場規模 2022年と2029年
地域別微生物抗菌薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Seres Therapeutics、 Assembly Biosciences、 Synthetic Biologics、 Interxon、 PureTech、 Synlogic、 Enterome BioScience、 4D Pharma、 Second Genome、 AOBiome、 Rebiotix、 Metabiomics、 Ritter Pharmaceuticals、 Symberix、 OpenBiome、 Azitra、 Osel
...

This research report provides a comprehensive analysis of the Microbial Antibacterial Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Microbial Antibacterial Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Microbial Antibacterial Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Microbial Antibacterial Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Microbial Antibacterial Drugs market presents opportunities for various stakeholders, including Gastrointestinal Disorders, Autoimmune Disorders. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Microbial Antibacterial Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Microbial Antibacterial Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Microbial Antibacterial Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Microbial Antibacterial Drugs market.
Market Overview: The report provides a comprehensive overview of the Microbial Antibacterial Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Oral Dosage Form, Enteric Capsules), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Microbial Antibacterial Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Microbial Antibacterial Drugs market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Microbial Antibacterial Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Microbial Antibacterial Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Microbial Antibacterial Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Microbial Antibacterial Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Microbial Antibacterial Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Microbial Antibacterial Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Microbial Antibacterial Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Oral Dosage Form
Enteric Capsules
Market segment by Application
Gastrointestinal Disorders
Autoimmune Disorders
Diabetes
Cancer
Others
Global Microbial Antibacterial Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
Rebiotix
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Osel
Outline of Major Chapters:
Chapter 1: Introduces the definition of Microbial Antibacterial Drugs, market overview.
Chapter 2: Global Microbial Antibacterial Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Microbial Antibacterial Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Microbial Antibacterial Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Microbial Antibacterial Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Microbial Antibacterial Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Microbial Antibacterial Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Microbial Antibacterial Drugs Overall Market Size
2.1 Global Microbial Antibacterial Drugs Market Size: 2022 VS 2029
2.2 Global Microbial Antibacterial Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Microbial Antibacterial Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Microbial Antibacterial Drugs Players in Global Market
3.2 Top Global Microbial Antibacterial Drugs Companies Ranked by Revenue
3.3 Global Microbial Antibacterial Drugs Revenue by Companies
3.4 Global Microbial Antibacterial Drugs Sales by Companies
3.5 Global Microbial Antibacterial Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Microbial Antibacterial Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Microbial Antibacterial Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Microbial Antibacterial Drugs Players in Global Market
3.8.1 List of Global Tier 1 Microbial Antibacterial Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Microbial Antibacterial Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Microbial Antibacterial Drugs Market Size Markets, 2022 & 2029
4.1.2 Oral Dosage Form
4.1.3 Enteric Capsules
4.2 By Type – Global Microbial Antibacterial Drugs Revenue & Forecasts
4.2.1 By Type – Global Microbial Antibacterial Drugs Revenue, 2018-2023
4.2.2 By Type – Global Microbial Antibacterial Drugs Revenue, 2024-2029
4.2.3 By Type – Global Microbial Antibacterial Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Microbial Antibacterial Drugs Sales & Forecasts
4.3.1 By Type – Global Microbial Antibacterial Drugs Sales, 2018-2023
4.3.2 By Type – Global Microbial Antibacterial Drugs Sales, 2024-2029
4.3.3 By Type – Global Microbial Antibacterial Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Microbial Antibacterial Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Microbial Antibacterial Drugs Market Size, 2022 & 2029
5.1.2 Gastrointestinal Disorders
5.1.3 Autoimmune Disorders
5.1.4 Diabetes
5.1.5 Cancer
5.1.6 Others
5.2 By Application – Global Microbial Antibacterial Drugs Revenue & Forecasts
5.2.1 By Application – Global Microbial Antibacterial Drugs Revenue, 2018-2023
5.2.2 By Application – Global Microbial Antibacterial Drugs Revenue, 2024-2029
5.2.3 By Application – Global Microbial Antibacterial Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Microbial Antibacterial Drugs Sales & Forecasts
5.3.1 By Application – Global Microbial Antibacterial Drugs Sales, 2018-2023
5.3.2 By Application – Global Microbial Antibacterial Drugs Sales, 2024-2029
5.3.3 By Application – Global Microbial Antibacterial Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Microbial Antibacterial Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Microbial Antibacterial Drugs Market Size, 2022 & 2029
6.2 By Region – Global Microbial Antibacterial Drugs Revenue & Forecasts
6.2.1 By Region – Global Microbial Antibacterial Drugs Revenue, 2018-2023
6.2.2 By Region – Global Microbial Antibacterial Drugs Revenue, 2024-2029
6.2.3 By Region – Global Microbial Antibacterial Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Microbial Antibacterial Drugs Sales & Forecasts
6.3.1 By Region – Global Microbial Antibacterial Drugs Sales, 2018-2023
6.3.2 By Region – Global Microbial Antibacterial Drugs Sales, 2024-2029
6.3.3 By Region – Global Microbial Antibacterial Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Microbial Antibacterial Drugs Revenue, 2018-2029
6.4.2 By Country – North America Microbial Antibacterial Drugs Sales, 2018-2029
6.4.3 US Microbial Antibacterial Drugs Market Size, 2018-2029
6.4.4 Canada Microbial Antibacterial Drugs Market Size, 2018-2029
6.4.5 Mexico Microbial Antibacterial Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Microbial Antibacterial Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Microbial Antibacterial Drugs Sales, 2018-2029
6.5.3 Germany Microbial Antibacterial Drugs Market Size, 2018-2029
6.5.4 France Microbial Antibacterial Drugs Market Size, 2018-2029
6.5.5 U.K. Microbial Antibacterial Drugs Market Size, 2018-2029
6.5.6 Italy Microbial Antibacterial Drugs Market Size, 2018-2029
6.5.7 Russia Microbial Antibacterial Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Microbial Antibacterial Drugs Market Size, 2018-2029
6.5.9 Benelux Microbial Antibacterial Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Microbial Antibacterial Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Microbial Antibacterial Drugs Sales, 2018-2029
6.6.3 China Microbial Antibacterial Drugs Market Size, 2018-2029
6.6.4 Japan Microbial Antibacterial Drugs Market Size, 2018-2029
6.6.5 South Korea Microbial Antibacterial Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Microbial Antibacterial Drugs Market Size, 2018-2029
6.6.7 India Microbial Antibacterial Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Microbial Antibacterial Drugs Revenue, 2018-2029
6.7.2 By Country – South America Microbial Antibacterial Drugs Sales, 2018-2029
6.7.3 Brazil Microbial Antibacterial Drugs Market Size, 2018-2029
6.7.4 Argentina Microbial Antibacterial Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Microbial Antibacterial Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Microbial Antibacterial Drugs Sales, 2018-2029
6.8.3 Turkey Microbial Antibacterial Drugs Market Size, 2018-2029
6.8.4 Israel Microbial Antibacterial Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Microbial Antibacterial Drugs Market Size, 2018-2029
6.8.6 UAE Microbial Antibacterial Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Seres Therapeutics
7.1.1 Seres Therapeutics Company Summary
7.1.2 Seres Therapeutics Business Overview
7.1.3 Seres Therapeutics Microbial Antibacterial Drugs Major Product Offerings
7.1.4 Seres Therapeutics Microbial Antibacterial Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Seres Therapeutics Key News & Latest Developments
7.2 Assembly Biosciences
7.2.1 Assembly Biosciences Company Summary
7.2.2 Assembly Biosciences Business Overview
7.2.3 Assembly Biosciences Microbial Antibacterial Drugs Major Product Offerings
7.2.4 Assembly Biosciences Microbial Antibacterial Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Assembly Biosciences Key News & Latest Developments
7.3 Synthetic Biologics
7.3.1 Synthetic Biologics Company Summary
7.3.2 Synthetic Biologics Business Overview
7.3.3 Synthetic Biologics Microbial Antibacterial Drugs Major Product Offerings
7.3.4 Synthetic Biologics Microbial Antibacterial Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Synthetic Biologics Key News & Latest Developments
7.4 Interxon
7.4.1 Interxon Company Summary
7.4.2 Interxon Business Overview
7.4.3 Interxon Microbial Antibacterial Drugs Major Product Offerings
7.4.4 Interxon Microbial Antibacterial Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Interxon Key News & Latest Developments
7.5 PureTech
7.5.1 PureTech Company Summary
7.5.2 PureTech Business Overview
7.5.3 PureTech Microbial Antibacterial Drugs Major Product Offerings
7.5.4 PureTech Microbial Antibacterial Drugs Sales and Revenue in Global (2018-2023)
7.5.5 PureTech Key News & Latest Developments
7.6 Synlogic
7.6.1 Synlogic Company Summary
7.6.2 Synlogic Business Overview
7.6.3 Synlogic Microbial Antibacterial Drugs Major Product Offerings
7.6.4 Synlogic Microbial Antibacterial Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Synlogic Key News & Latest Developments
7.7 Enterome BioScience
7.7.1 Enterome BioScience Company Summary
7.7.2 Enterome BioScience Business Overview
7.7.3 Enterome BioScience Microbial Antibacterial Drugs Major Product Offerings
7.7.4 Enterome BioScience Microbial Antibacterial Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Enterome BioScience Key News & Latest Developments
7.8 4D Pharma
7.8.1 4D Pharma Company Summary
7.8.2 4D Pharma Business Overview
7.8.3 4D Pharma Microbial Antibacterial Drugs Major Product Offerings
7.8.4 4D Pharma Microbial Antibacterial Drugs Sales and Revenue in Global (2018-2023)
7.8.5 4D Pharma Key News & Latest Developments
7.9 Second Genome
7.9.1 Second Genome Company Summary
7.9.2 Second Genome Business Overview
7.9.3 Second Genome Microbial Antibacterial Drugs Major Product Offerings
7.9.4 Second Genome Microbial Antibacterial Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Second Genome Key News & Latest Developments
7.10 AOBiome
7.10.1 AOBiome Company Summary
7.10.2 AOBiome Business Overview
7.10.3 AOBiome Microbial Antibacterial Drugs Major Product Offerings
7.10.4 AOBiome Microbial Antibacterial Drugs Sales and Revenue in Global (2018-2023)
7.10.5 AOBiome Key News & Latest Developments
7.11 Rebiotix
7.11.1 Rebiotix Company Summary
7.11.2 Rebiotix Business Overview
7.11.3 Rebiotix Microbial Antibacterial Drugs Major Product Offerings
7.11.4 Rebiotix Microbial Antibacterial Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Rebiotix Key News & Latest Developments
7.12 Metabiomics
7.12.1 Metabiomics Company Summary
7.12.2 Metabiomics Business Overview
7.12.3 Metabiomics Microbial Antibacterial Drugs Major Product Offerings
7.12.4 Metabiomics Microbial Antibacterial Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Metabiomics Key News & Latest Developments
7.13 Ritter Pharmaceuticals
7.13.1 Ritter Pharmaceuticals Company Summary
7.13.2 Ritter Pharmaceuticals Business Overview
7.13.3 Ritter Pharmaceuticals Microbial Antibacterial Drugs Major Product Offerings
7.13.4 Ritter Pharmaceuticals Microbial Antibacterial Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Ritter Pharmaceuticals Key News & Latest Developments
7.14 Symberix
7.14.1 Symberix Company Summary
7.14.2 Symberix Business Overview
7.14.3 Symberix Microbial Antibacterial Drugs Major Product Offerings
7.14.4 Symberix Microbial Antibacterial Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Symberix Key News & Latest Developments
7.15 OpenBiome
7.15.1 OpenBiome Company Summary
7.15.2 OpenBiome Business Overview
7.15.3 OpenBiome Microbial Antibacterial Drugs Major Product Offerings
7.15.4 OpenBiome Microbial Antibacterial Drugs Sales and Revenue in Global (2018-2023)
7.15.5 OpenBiome Key News & Latest Developments
7.16 Azitra
7.16.1 Azitra Company Summary
7.16.2 Azitra Business Overview
7.16.3 Azitra Microbial Antibacterial Drugs Major Product Offerings
7.16.4 Azitra Microbial Antibacterial Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Azitra Key News & Latest Developments
7.17 Osel
7.17.1 Osel Company Summary
7.17.2 Osel Business Overview
7.17.3 Osel Microbial Antibacterial Drugs Major Product Offerings
7.17.4 Osel Microbial Antibacterial Drugs Sales and Revenue in Global (2018-2023)
7.17.5 Osel Key News & Latest Developments
8 Global Microbial Antibacterial Drugs Production Capacity, Analysis
8.1 Global Microbial Antibacterial Drugs Production Capacity, 2018-2029
8.2 Microbial Antibacterial Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Microbial Antibacterial Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Microbial Antibacterial Drugs Supply Chain Analysis
10.1 Microbial Antibacterial Drugs Industry Value Chain
10.2 Microbial Antibacterial Drugs Upstream Market
10.3 Microbial Antibacterial Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Microbial Antibacterial Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Microbial Antibacterial Drugs in Global Market
Table 2. Top Microbial Antibacterial Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Microbial Antibacterial Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Microbial Antibacterial Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Microbial Antibacterial Drugs Sales by Companies, (Kilotons), 2018-2023
Table 6. Global Microbial Antibacterial Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Microbial Antibacterial Drugs Price (2018-2023) & (US$/Ton)
Table 8. Global Manufacturers Microbial Antibacterial Drugs Product Type
Table 9. List of Global Tier 1 Microbial Antibacterial Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Microbial Antibacterial Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Microbial Antibacterial Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Microbial Antibacterial Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Microbial Antibacterial Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Microbial Antibacterial Drugs Sales (Kilotons), 2018-2023
Table 15. By Type - Global Microbial Antibacterial Drugs Sales (Kilotons), 2024-2029
Table 16. By Application – Global Microbial Antibacterial Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Microbial Antibacterial Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Microbial Antibacterial Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Microbial Antibacterial Drugs Sales (Kilotons), 2018-2023
Table 20. By Application - Global Microbial Antibacterial Drugs Sales (Kilotons), 2024-2029
Table 21. By Region – Global Microbial Antibacterial Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Microbial Antibacterial Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Microbial Antibacterial Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Microbial Antibacterial Drugs Sales (Kilotons), 2018-2023
Table 25. By Region - Global Microbial Antibacterial Drugs Sales (Kilotons), 2024-2029
Table 26. By Country - North America Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Microbial Antibacterial Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Microbial Antibacterial Drugs Sales, (Kilotons), 2018-2023
Table 29. By Country - North America Microbial Antibacterial Drugs Sales, (Kilotons), 2024-2029
Table 30. By Country - Europe Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Microbial Antibacterial Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Microbial Antibacterial Drugs Sales, (Kilotons), 2018-2023
Table 33. By Country - Europe Microbial Antibacterial Drugs Sales, (Kilotons), 2024-2029
Table 34. By Region - Asia Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Microbial Antibacterial Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Microbial Antibacterial Drugs Sales, (Kilotons), 2018-2023
Table 37. By Region - Asia Microbial Antibacterial Drugs Sales, (Kilotons), 2024-2029
Table 38. By Country - South America Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Microbial Antibacterial Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Microbial Antibacterial Drugs Sales, (Kilotons), 2018-2023
Table 41. By Country - South America Microbial Antibacterial Drugs Sales, (Kilotons), 2024-2029
Table 42. By Country - Middle East & Africa Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Microbial Antibacterial Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Microbial Antibacterial Drugs Sales, (Kilotons), 2018-2023
Table 45. By Country - Middle East & Africa Microbial Antibacterial Drugs Sales, (Kilotons), 2024-2029
Table 46. Seres Therapeutics Company Summary
Table 47. Seres Therapeutics Microbial Antibacterial Drugs Product Offerings
Table 48. Seres Therapeutics Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 49. Seres Therapeutics Key News & Latest Developments
Table 50. Assembly Biosciences Company Summary
Table 51. Assembly Biosciences Microbial Antibacterial Drugs Product Offerings
Table 52. Assembly Biosciences Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 53. Assembly Biosciences Key News & Latest Developments
Table 54. Synthetic Biologics Company Summary
Table 55. Synthetic Biologics Microbial Antibacterial Drugs Product Offerings
Table 56. Synthetic Biologics Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 57. Synthetic Biologics Key News & Latest Developments
Table 58. Interxon Company Summary
Table 59. Interxon Microbial Antibacterial Drugs Product Offerings
Table 60. Interxon Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 61. Interxon Key News & Latest Developments
Table 62. PureTech Company Summary
Table 63. PureTech Microbial Antibacterial Drugs Product Offerings
Table 64. PureTech Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 65. PureTech Key News & Latest Developments
Table 66. Synlogic Company Summary
Table 67. Synlogic Microbial Antibacterial Drugs Product Offerings
Table 68. Synlogic Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 69. Synlogic Key News & Latest Developments
Table 70. Enterome BioScience Company Summary
Table 71. Enterome BioScience Microbial Antibacterial Drugs Product Offerings
Table 72. Enterome BioScience Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 73. Enterome BioScience Key News & Latest Developments
Table 74. 4D Pharma Company Summary
Table 75. 4D Pharma Microbial Antibacterial Drugs Product Offerings
Table 76. 4D Pharma Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 77. 4D Pharma Key News & Latest Developments
Table 78. Second Genome Company Summary
Table 79. Second Genome Microbial Antibacterial Drugs Product Offerings
Table 80. Second Genome Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 81. Second Genome Key News & Latest Developments
Table 82. AOBiome Company Summary
Table 83. AOBiome Microbial Antibacterial Drugs Product Offerings
Table 84. AOBiome Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 85. AOBiome Key News & Latest Developments
Table 86. Rebiotix Company Summary
Table 87. Rebiotix Microbial Antibacterial Drugs Product Offerings
Table 88. Rebiotix Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 89. Rebiotix Key News & Latest Developments
Table 90. Metabiomics Company Summary
Table 91. Metabiomics Microbial Antibacterial Drugs Product Offerings
Table 92. Metabiomics Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 93. Metabiomics Key News & Latest Developments
Table 94. Ritter Pharmaceuticals Company Summary
Table 95. Ritter Pharmaceuticals Microbial Antibacterial Drugs Product Offerings
Table 96. Ritter Pharmaceuticals Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 97. Ritter Pharmaceuticals Key News & Latest Developments
Table 98. Symberix Company Summary
Table 99. Symberix Microbial Antibacterial Drugs Product Offerings
Table 100. Symberix Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 101. Symberix Key News & Latest Developments
Table 102. OpenBiome Company Summary
Table 103. OpenBiome Microbial Antibacterial Drugs Product Offerings
Table 104. OpenBiome Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 105. OpenBiome Key News & Latest Developments
Table 106. Azitra Company Summary
Table 107. Azitra Microbial Antibacterial Drugs Product Offerings
Table 108. Azitra Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 109. Azitra Key News & Latest Developments
Table 110. Osel Company Summary
Table 111. Osel Microbial Antibacterial Drugs Product Offerings
Table 112. Osel Microbial Antibacterial Drugs Sales (Kilotons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 113. Osel Key News & Latest Developments
Table 114. Microbial Antibacterial Drugs Production Capacity (Kilotons) of Key Manufacturers in Global Market, 2021-2023 (Kilotons)
Table 115. Global Microbial Antibacterial Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 116. Global Microbial Antibacterial Drugs Production by Region, 2018-2023 (Kilotons)
Table 117. Global Microbial Antibacterial Drugs Production by Region, 2024-2029 (Kilotons)
Table 118. Microbial Antibacterial Drugs Market Opportunities & Trends in Global Market
Table 119. Microbial Antibacterial Drugs Market Drivers in Global Market
Table 120. Microbial Antibacterial Drugs Market Restraints in Global Market
Table 121. Microbial Antibacterial Drugs Raw Materials
Table 122. Microbial Antibacterial Drugs Raw Materials Suppliers in Global Market
Table 123. Typical Microbial Antibacterial Drugs Downstream
Table 124. Microbial Antibacterial Drugs Downstream Clients in Global Market
Table 125. Microbial Antibacterial Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Microbial Antibacterial Drugs Segment by Type in 2022
Figure 2. Microbial Antibacterial Drugs Segment by Application in 2022
Figure 3. Global Microbial Antibacterial Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Microbial Antibacterial Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Microbial Antibacterial Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Microbial Antibacterial Drugs Sales in Global Market: 2018-2029 (Kilotons)
Figure 8. The Top 3 and 5 Players Market Share by Microbial Antibacterial Drugs Revenue in 2022
Figure 9. By Type - Global Microbial Antibacterial Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Microbial Antibacterial Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Microbial Antibacterial Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Microbial Antibacterial Drugs Price (US$/Ton), 2018-2029
Figure 13. By Application - Global Microbial Antibacterial Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Microbial Antibacterial Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Microbial Antibacterial Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Microbial Antibacterial Drugs Price (US$/Ton), 2018-2029
Figure 17. By Region - Global Microbial Antibacterial Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Microbial Antibacterial Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Microbial Antibacterial Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Microbial Antibacterial Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Microbial Antibacterial Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Microbial Antibacterial Drugs Sales Market Share, 2018-2029
Figure 23. US Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Microbial Antibacterial Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Microbial Antibacterial Drugs Sales Market Share, 2018-2029
Figure 28. Germany Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Microbial Antibacterial Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Microbial Antibacterial Drugs Sales Market Share, 2018-2029
Figure 37. China Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Microbial Antibacterial Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Microbial Antibacterial Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Microbial Antibacterial Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Microbial Antibacterial Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Microbial Antibacterial Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Microbial Antibacterial Drugs Production Capacity (Kilotons), 2018-2029
Figure 53. The Percentage of Production Microbial Antibacterial Drugs by Region, 2022 VS 2029
Figure 54. Microbial Antibacterial Drugs Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 非吸収性抗菌縫合糸のグローバル市場展望 2023年-2029年：天然非吸収性縫合糸、合成非吸収性縫合糸
  • 抗菌PVCフィルムのグローバル市場展望 2023年-2029年：透明塩ビフィルム、着色塩ビフィルム
  • 抗菌コーキングのグローバル市場展望 2023年-2029年：ホワイト、その他
  • サラセミア&合併症治療薬のグローバル市場展望 2023年-2029年：サラセミアマイルド、サラセミア中等度、サラセミアメジャー
  • 前頭洞炎治療薬のグローバル市場展望 2023年-2029年：抗生物質、コルチコステロイド、鼻詰まり除去剤
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14425 )"微生物抗菌薬のグローバル市場展望 2023年-2029年：経口剤、腸溶性カプセル" (英文：Microbial Antibacterial Drugs Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。